Feel an immediate sense of clarity, so you can properly assess complex situations and work effectively under intense pressure
The purpose of this study is to measure change in glycemic control and prandial insulin independency over 52 weeks with teplizumab Investigator Michael J Haller Status Accepting Candidates Ages 1 Year - 25 Years Sexes All GNTI-122-T1D-1001 This is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an investigational cell therapy manufactured from a participant's own blood Investigator Brittany S Bruggeman Status Accepting Candidates Ages 18 Years - 55 Years Sexes All TN-36 This Phase 2 study is a 2-arm, multi-center, double-masked (masking of the participant, care provider and investigator), placebo-controlled, 2:1 randomized trial design in new onset T1D participants (within 100 days of diagnosis)
[DOI] [PubMed] [Google Scholar] [50].Zhang X, Min X, Li C, Benjamin IJ, Qian B, Zhang X, Ding Z, Gao X, Yao Y, Ma Y, Cheng Y, Liu L, Involvement of reductive stress in the cardiomyopathy in transgenic mice with cardiac-specific overexpression of heat shock protein 27
BPC-157 Known for its regenerative properties, BPC-157 is often used for tissue and soft tissue repair
